Orphazyme - Company announcement - Major shareholder announcement
Kurs
+37,00%
Kurs
+37,00%
Kalender
| Tid* | ||
| 2025-08-08 | 17:00 | Kvartalsrapport 2025-Q2 |
| 2025-03-26 | N/A | Årsstämma |
| 2025-02-28 | 07:00 | Bokslutskommuniké 2024 |
| 2024-08-20 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-17 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2024-04-11 | - | Årsstämma |
| 2024-04-04 | - | Bokslutskommuniké 2023 |
| 2023-12-06 | - | Split STRAP 1000:1 |
| 2023-11-02 | - | Extra Bolagsstämma 2023 |
| 2023-09-12 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-22 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2023-05-17 | - | Årsstämma |
| 2023-04-25 | - | Bokslutskommuniké 2022 |
| 2022-09-26 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-29 | - | Årsstämma |
| 2022-06-28 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2022-06-07 | - | Bokslutskommuniké 2021 |
| 2022-02-15 | - | Extra Bolagsstämma 2022 |
| 2021-08-31 | - | Kvartalsrapport 2021-Q2 |
| 2021-03-26 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2021-03-25 | - | Årsstämma |
| 2021-03-02 | - | Bokslutskommuniké 2020 |
| 2020-09-21 | - | Extra Bolagsstämma 2020 |
| 2020-08-28 | - | Kvartalsrapport 2020-Q2 |
| 2020-03-27 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2020-03-26 | - | Årsstämma |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
| 2020-01-25 | - | Extra Bolagsstämma 2019 |
| 2019-08-28 | - | Kvartalsrapport 2019-Q2 |
| 2019-03-28 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2019-03-27 | - | Årsstämma |
| 2019-03-01 | - | Bokslutskommuniké 2018 |
| 2018-08-28 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-13 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2018-04-12 | - | Årsstämma |
| 2018-03-15 | - | Bokslutskommuniké 2017 |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Small Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2023-05-17 18:51:34
Company announcement
Orphazyme A/S
No. 09/2023
Ole Maaløes Vej 3
DK-2200 Copenhagen N
www.orphazyme.com
Company Registration No. 32266355
Major shareholder announcement
Copenhagen, Denmark, May 17, 2023 – Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from MH Investment ApS, that as of May 16, 2023, MH Investment ApS holds shares corresponding to 10.00% of the total share capital and voting rights in the Company.
For additional information, please contact
Orphazyme A/S
Michael Hove, Chairman of the board +45 28 12 66 09